Inovio Pharmaceuticals Inc (INO)

[Ckbike]

Look at ACAD. Went from > $150 million market cap to $1.6 billion in under a year all based on their lead drug Pimavanserin showing great safety and efficacy in PHIII trials. I went in @ $1.50 and sold when it broke the $6 mark. Should have held longer now that it's hovering around $20 but still made a decent profit so can't complain.

What this shows is the potential INO has in their pipeline. ACAD's Pimavanserin is expected to generate $2 billion/yr. in on and off label uses to treat a number of neurological diseases should they receive FDA approval. They will not file the PFUDA until later this year. INO, while still in the early stages, has showed tremendous potential in treating/preventing several large diseases and illnesses, i.e. HIV, Flu, cancer, etc. I think you can see where I am going with this. If just one of their vaccine treatments proves itself then INO has a blockbuster drug on it's hands. However, should several of their vaccines demonstrate safety and efficacy in large disease sets we're talking about tens of billions in revenue. At that point a share price at $10 would be a bargain and $100 may be fair value. Long way to go to get there and I'll be looking to add on any dips to the $1.40 - 1.50 range. Enjoy the ride everyone!